Daiichi Sankyo, Tanabe Mitsubishi Pharmaceutical, Ono Pharmaceutical, Keio University, Kochi University, and the National Institute of Health and Nutrition have launched joint research on the pathophysiology of immunoinflammatory diseases and related research on drug...
The committee will develop views whether genomic editing technology is the object of the Cartagena method from the viewpoint of proper operation of genetically modified organisms (Cartagena protocol). Nikkei Biotech news release, May 31, 2018
The government is working on revitalizing the space industry in Japan. The „S-Matching) is intended to facilitate matching between individuals and venture companies having new business ideas in the space field. Together with public and private sectors such as Japan...
Chugai Pharmaceutical announced that the humanized anti-human IL-6 receptor monoclonal antibody Actemra® for intravenous infusion 80 mg, 200 mg, 400 mg” : Tocilizumab (genetic recombination)] (hereinafter referred to as Actemra) was approved by the MHLW for an...
The company manufactures non-standard peptides for pharmaceutical use as APIs and will operate a factory with a floor area of over 10,000 m2 in the Settsu factory of Shionogi & Co., which is also a shareholder, from autumn of 2019. An R & D laboratory will...
